Liestal, Switzerland and Weybridge, England (ots/PRNewswire) – – Santhera and Idis Partner to Facilitate Patient Access to Friedreich’s Ataxia Drug Santhera Pharmaceuticals, a Swiss specialty pharmaceutical company focused on orphan neuromuscular diseases and Idis announced today that Catena(R) will be made available on a named patient basis in Europe. Santhera’s Named Patient Programme (NPP) managed [...]
Tag Archive > Eligible Patients
Landmark EchoCRT trial enrolls first European patients
(pressebox) Berlin, 02.12.2008 – BIOTRONIK announces European rollout of the EchoCRT Trial investigating the life-saving benefits of cardiac resynchronization therapy in patients with heart failure who currently do not receive device therapy. BIOTRONIK announced that the first European patients have been enrolled into the EchoCRT (Echocardiography guided Cardiac Resynchronization Therapy) trial by the team of [...]
